Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Pension (2018 - 2025)

Historic Pension for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to $978.4 million.

  • Takeda Pharmaceutical's Pension rose 442.63% to $978.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $978.4 million, marking a year-over-year increase of 442.63%. This contributed to the annual value of $889.1 million for FY2025, which is 1088.75% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Pension of $978.4 million as of Q4 2025, which was up 442.63% from $978.0 million recorded in Q3 2025.
  • Takeda Pharmaceutical's Pension's 5-year high stood at $1.5 billion during Q1 2021, with a 5-year trough of $887.7 million in Q1 2025.
  • Moreover, its 5-year median value for Pension was $978.0 million (2025), whereas its average is $1.1 billion.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Pension tumbled by 3706.89% in 2022, and later skyrocketed by 735.54% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Pension (Quarter) stood at $1.5 billion in 2021, then tumbled by 37.07% to $940.1 million in 2022, then fell by 0.01% to $940.0 million in 2023, then decreased by 0.33% to $936.9 million in 2024, then increased by 4.43% to $978.4 million in 2025.
  • Its last three reported values are $978.4 million in Q4 2025, $978.0 million for Q3 2025, and $978.0 million during Q2 2025.